HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Markers of cell proliferation, apoptosis, and angiogenesis in thyroid adenomas: a comparative immunohistochemical and genetic investigation of functioning and nonfunctioning nodules.

AbstractOBJECTIVE:
To perform (i) an immunohistochemical investigation of cell proliferation, apoptosis, angiogenesis, and malignancy markers in 15 functioning and 15 nonfunctioning thyroid adenomas, and in normal adjacent tissue, and (ii) a genetic analysis of thyroid-stimulating hormone receptor (TSH-r), Gsalpha, and RAS mutations in the same group of adenomas, in order to describe their expression within tissues and to correlate them with the hormonal functioning.
DESIGN:
Thirty patients who underwent surgery for a solitary thyroid nodule were included in the study. Adenomas and normal adjacent tissues were evaluated by immunohistochemistry using the following antibodies: MIB-1 for proliferative activity, bcl-2 and mutant p53 for apoptosis control, vascular endothelial growth factor-A (VEGF-A) for angiogenic activity, and galectin-3 as a marker for malignancy. To calculate microvascular density, "hot spots" were selected and defined by cells positive for CD34 staining. Genetic analysis for TSH-r, Gsalpha, and H-, K-, and N-RAS mutations was performed on adenoma specimens.
MAIN OUTCOMES:
Our results evidenced that a proportion of both functioning and nonfunctioning adenomas showed immunohistochemical phenotypes similar to normal adjacent tissue. No differences were found between functioning and nonfunctioning thyroid adenomas with regard to the expression of markers associated to angiogenesis (VEGF-A, microvascular density) and apoptosis control (mutant p53, bcl-2). All adenomas resulted negative for galectin-3 immunostaining. MIB-1 was the only marker showing a substantial difference of expression between the two groups of adenomas. TSH-r mutations were found in 12 out of 15 functioning adenomas, whereas the absence of Gsalpha and H-, K-, and N-RAS mutations was demonstrated in all adenomas.
CONCLUSIONS:
Our data suggest that the differences between functioning and nonfunctioning thyroid adenomas are restricted to the genetic mutations of the TSH-r, to the hormonal status of tumors, and to the proliferative activity, not involving markers of apoptosis control and angiogenesis.
AuthorsPaolo Viacava, Guido Bocci, Massimo Tonacchera, Giovanni Fanelli, Melissa DeServi, Patrizia Agretti, Edoardo Berti, Orlando Goletti, Paolo Aretini, Maria Letizia Resta, Generoso Bevilacqua, Antonio Giuseppe Naccarato
JournalThyroid : official journal of the American Thyroid Association (Thyroid) Vol. 17 Issue 3 Pg. 191-7 (Mar 2007) ISSN: 1050-7256 [Print] United States
PMID17381350 (Publication Type: Journal Article)
Chemical References
  • Antigens, CD34
  • Biomarkers, Tumor
  • Proto-Oncogene Proteins c-bcl-2
  • Tumor Suppressor Protein p53
Topics
  • Adenoma (genetics, metabolism, pathology)
  • Antigens, CD34 (biosynthesis)
  • Apoptosis
  • Biomarkers, Tumor (metabolism)
  • Cell Proliferation
  • Humans
  • Immunohistochemistry (methods)
  • Neovascularization, Pathologic
  • Proto-Oncogene Proteins c-bcl-2 (metabolism)
  • Sequence Analysis, DNA
  • Thyroid Neoplasms (genetics, metabolism, pathology)
  • Tumor Suppressor Protein p53 (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: